The present invention relates to compounds of the formulae (I)-(XII), wherein R
1
-R
71
, A, B, X, Y, G, L and Z are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer.
[EN] 9-AZABICYCLO'3.3.1!NON-6-EE DERIVATIVES WITH A HETEROATOM AT THE 3-POSITION AS RENIN INHIBITORS<br/>[FR] DERIVES DE 9-AZABICYCLO'3.3.1!NON-6-EE A HETEROATOME EN POSITION 3 SERVANT D'INHIBITEURS DE LA RENINE
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2004096366A1
公开(公告)日:2004-11-11
The invention relates to novel 9-azabicyclo[3.3.1]nonene derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
[EN] INDOLINONE HYDRAZIDES AS C-MET INHIBITORS<br/>[FR] HYDRAZIDES D'INDOLINONE UTILISES EN TANT QU'INHIBITEURS DU RECEPTEUR C-MET